Unity Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Unity Biotechnology has a total shareholder equity of $19.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $53.5M and $33.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$33.98m |
Equity | US$19.75m |
Total liabilities | US$33.77m |
Total assets | US$53.52m |
Recent financial health updates
Will Unity Biotechnology (NASDAQ:UBX) Spend Its Cash Wisely?
Jul 12Here's Why We're A Bit Worried About Unity Biotechnology's (NASDAQ:UBX) Cash Burn Situation
Mar 05Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
Nov 18Recent updates
Will Unity Biotechnology (NASDAQ:UBX) Spend Its Cash Wisely?
Jul 12Here's Why We're A Bit Worried About Unity Biotechnology's (NASDAQ:UBX) Cash Burn Situation
Mar 05Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
Nov 18UNITY Biotechnology falls 7% on reverse stock split
Oct 19Unity Biotechnology cuts stock sales agreement in half to $25M
Aug 19Unity Biotechnology GAAP EPS of -$0.19 beats by $0.10, revenue of $0.24M
Aug 12A Look At Unity's UBX1325 Phase 1 Results
Jul 26Trade Alert: The Co-Founder Of Unity Biotechnology, Inc. (NASDAQ:UBX), Nathaniel David, Has Sold Some Shares Recently
Dec 22A Look Inside Unity Bio's Transition To An Ophthalmology Company
Nov 27Financial Position Analysis
Short Term Liabilities: UBX's short term assets ($35.8M) exceed its short term liabilities ($8.8M).
Long Term Liabilities: UBX's short term assets ($35.8M) exceed its long term liabilities ($25.0M).
Debt to Equity History and Analysis
Debt Level: UBX is debt free.
Reducing Debt: UBX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: UBX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: UBX has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 10.8% each year.